Feasible and desirable future targets for reducing the costs of hospital infections
- 1 June 1991
- journal article
- research article
- Published by Elsevier in Journal of Hospital Infection
- Vol. 18, 94-98
- https://doi.org/10.1016/0195-6701(91)90009-w
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative SepsisJAMA, 1991
- Nosocomial gram-negative bloodstream isolates: a comparison of in vitro antibiotic potencyJournal of Hospital Infection, 1989
- Cost-effectiveness in hospital infection control—lessons for the 1990sJournal of Hospital Infection, 1989
- Hospital-acquired candidemia. The attributable mortality and excess length of stayArchives of internal medicine (1960), 1988
- Cost of nosocomial infection: Relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infectionsAmerican Journal of Infection Control, 1988
- The Mortality of Hospital-Acquired Bloodstream Infections: Need for a New Vital Statistic?International Journal of Epidemiology, 1988
- Nosocomial Pneumonia in Intubated Patients Given Sucralfate as Compared with Antacids or Histamine Type 2 BlockersNew England Journal of Medicine, 1987
- Catheter-associated bacteriuria. Failure to reduce attack rates using periodic instillations of a disinfectant into urinary drainage systemsJAMA, 1984
- Development of a Statewide Program for Surveillance and Reporting of Hospital-Acquired InfectionsThe Journal of Infectious Diseases, 1979
- Postoperative Wound InfectionAnnals of Surgery, 1977